Furthermore, the median CDC42 expression in patients with AIS and in controls was 0.500 (IQR: 0.320–0.800) and 1.005 (IQR: 0.760–1.828), respectively. This evidence concerns the gene CDC42 and androgen insensitivity syndrome.